HTA183 HTA and Regulatory Perspectives on Robustness of Evidence and Management of Uncertainties
Year: 2025
Type: article
Language: en
Topic: Health Systems, Economic Evaluations, Quality of Life
Authors and affiliations:
raw_author_name: David McConnell
raw_affiliation_strings: National Centre for Pharmacoeconomics, Dublin, Ireland
raw_author_name: Dominik Karres
raw_affiliation_strings: European Medicines Agency, Amsterdam, Netherlands
raw_author_name: Lea Trela-Larsen
raw_affiliation_strings: National Centre for Pharmacoeconomics, Dublin, Ireland
raw_author_name: Beate Wieseler
raw_affiliation_strings: Institute for Quality and Efficiency in Healthcare (IQWiG), Cologne, Germany
raw_author_name: Randi Krontveit
raw_affiliation_strings: Norwegian Medicines Agency, Oslo, Norway
raw_author_name: Kirsti Hjelme
raw_affiliation_strings: Norwegian Medicines Agency, Oslo, Norway
raw_author_name: Hilde Røshol
raw_affiliation_strings: Norwegian Medicines Agency, Oslo, Norway
raw_author_name: Philip Kranz
raw_affiliation_strings: Institute for Quality and Efficiency in Healthcare (IQWiG), Cologne, Germany
raw_author_name: Mattias Neyt
raw_affiliation_strings: Belgian Health Care Knowledge Centre, Brussels, Belgium
raw_author_name: Sofia Dias
raw_affiliation_strings: University of York, York, United Kingdom
raw_author_name: Lars Beckmann
raw_affiliation_strings: Institute for Quality and Efficiency in Healthcare (IQWiG), Cologne, Germany
raw_author_name: Frank Hulstaert
raw_affiliation_strings: Belgian Health Care Knowledge Centre, Brussels, Belgium
raw_author_name: Marc Van de Casteele
raw_affiliation_strings: National Institute for Health and Disability Insurance (RIZIV-INAMI), Brussels, Belgium
raw_author_name: Joy Leahy
raw_affiliation_strings: National Centre for Pharmacoeconomics, Dublin, Ireland
raw_author_name: Niamh Carey
raw_affiliation_strings: National Centre for Pharmacoeconomics, Dublin, Ireland
raw_author_name: Hans Hillege
raw_affiliation_strings: UMCG, Haren, Netherlands
raw_author_name: Michael Berntgen
raw_affiliation_strings: European Medicines Agency, Amsterdam, Netherlands
raw_author_name: Denise Umuhire
raw_affiliation_strings: European Medicines Agency, Amsterdam, Netherlands
raw_author_name: Peter GM. Mol
raw_affiliation_strings: Medicines Evaluation Board (CBG-MEB), Utrecht, Netherlands
raw_author_name: Ralf Bender
raw_affiliation_strings: Institute for Quality and Efficiency in Healthcare (IQWiG), Cologne, Germany
raw_author_name: Anke Schulz
raw_affiliation_strings: Institute for Quality and Efficiency in Healthcare (IQWiG), Cologne, Germany
raw_author_name: María José del Pino
raw_affiliation_strings: Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain
raw_author_name: Cathal Walsh
raw_affiliation_strings: Trinity College Dublin, Dublin, Ireland
raw_author_name: Kit Roes
raw_affiliation_strings: Radboud University Medical Center, Nijmegen, Netherlands
raw_author_name: Patrice Verpillat
raw_affiliation_strings: European Medicines Agency, Amsterdam, Netherlands
raw_author_name: Ilona Reischl
raw_affiliation_strings: Austrian Federal Office For Safety In Health Care, Vienna, Austria
raw_author_name: Emmely de Vries
raw_affiliation_strings: Medicines Evaluation Board (CBG-MEB), Utrecht, Netherlands
raw_author_name: Frauke Naumann-Winter
raw_affiliation_strings: Federal Institute For Drugs And Medical Devices, Bonn, Germany
raw_author_name: Olga Kholmanskikh
raw_affiliation_strings: Federal Agency For Medicines And Health Products, Brussels, Belgium
raw_author_name: Filip Josephson
raw_affiliation_strings: Swedish Medical Products Agency, Uppsala, Sweden
raw_author_name: Bruno Delafont
raw_affiliation_strings: National Agency For The Safety Of Medicine And Health Products, Paris, France
raw_author_name: Christian Gartner
raw_affiliation_strings: Austrian Federal Office For Safety In Health Care, Vienna, Austria
raw_author_name: Finbarr Leacy
raw_affiliation_strings: Health Products Regulatory Authority, Dublin, Ireland
raw_author_name: Sylvie Benchetrit
raw_affiliation_strings: National Agency For The Safety Of Medicine And Health Products, Paris, France
raw_author_name: Roisin Adams
raw_affiliation_strings: National Centre for Pharmacoeconomics, Dublin, Ireland
raw_author_name: Bruno Sepodes
raw_affiliation_strings: National Authority Of Medicines And Health Products (INFARMED), Lisbon, Portugal